Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus in 6-Year-Olds
NCT04817917Phase 4Unknown
- Start
- Mar 2021
- Primary completion
- Sep 2022
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Japanese encephalitis vaccine in Japanese encephalitis (JE). Status: unknown.
02
Drugs
Japanese encephalitis vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT04817917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817917.